The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

All News

Treating bladder infections with viruses
Infectious Disease & AMR

Treating bladder infections with viruses

JUL 25, 2023
Distinguishing Strains in Microbiome Samples: Considerations and Challenges
Editor's Choice

Distinguishing Strains in Microbiome Samples: Considerations and Challenges

JUL 19, 2023
Ensuring standardised data collection for microbiome research, a sit down with DNA Genotek’s Heloise Breton and Austin Udocor
Pharma & Human Health

Ensuring standardised data collection for microbiome research, a sit down with DNA Genotek’s Heloise Breton and Austin Udocor

JUL 12, 2023
Dutch government reserves €200 million for Holomicrobiome Institute
Finance

Dutch government reserves €200 million for Holomicrobiome Institute

JUL 5, 2023
Additional Infant Bacterial Therapeutics product receives FDA orphan drug designation
Infectious Disease & AMR

Additional Infant Bacterial Therapeutics product receives FDA orphan drug designation

JUL 5, 2023
Adare Pharma Solutions announces divestiture of postbiotics pioneer Adare Biome to dsm-firmenich
Biotics and Supplements

Adare Pharma Solutions announces divestiture of postbiotics pioneer Adare Biome to dsm-firmenich

JUL 4, 2023
Exeliom Biosciences Announces Series A Extension and Final Closing with Total of €24 Million
Finance

Exeliom Biosciences Announces Series A Extension and Final Closing with Total of €24 Million

JUL 3, 2023
Pendulum Therapeutics Announces Strategic Partnership and $10M Investment from Fonterra
Finance

Pendulum Therapeutics Announces Strategic Partnership and $10M Investment from Fonterra

JUL 3, 2023
Concerto Biosciences Announces Discovery Initiative to Combat Recurrent Vaginal Yeast Infections
Infectious Disease & AMR

Concerto Biosciences Announces Discovery Initiative to Combat Recurrent Vaginal Yeast Infections

JUN 30, 2023
Freya Biosciences Announces Positive Topline Clinical Trial Results for FB101 in Women with Asymptomatic Vaginal Dysbiosis
Clinical & Manufacturing

Freya Biosciences Announces Positive Topline Clinical Trial Results for FB101 in Women with Asymptomatic Vaginal Dysbiosis

JUN 28, 2023
New “atlas” maps bacteria and metabolites associated with elevated risk of cardiovascular disease
Pharma & Human Health

New “atlas” maps bacteria and metabolites associated with elevated risk of cardiovascular disease

JUN 26, 2023